Glucuronidation does not suppress the estrogenic activity of quercetin in yeast and human breast cancer cell model systems.
暂无分享,去创建一个
[1] S. Ottonello,et al. Anti-estrogenic activity of a human resveratrol metabolite. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] F. A. Resende,et al. Evaluation of Estrogenic Potential of Flavonoids Using a Recombinant Yeast Strain and MCF7/BUS Cell Proliferation Assay , 2013, PloS one.
[3] Dongyan Zhang,et al. Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation. , 2013, Molecular nutrition & food research.
[4] A. Rodriguez-Mateos,et al. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. , 2013, Antioxidants & redox signaling.
[5] G. Pasinetti,et al. Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] D. Ardigò,et al. Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects. , 2012, Food & function.
[7] Young In Park,et al. Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[8] G. Rimbach,et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. , 2011, The Journal of nutritional biochemistry.
[9] M. Clifford,et al. Bioavailability of dietary flavonoids and phenolic compounds. , 2010, Molecular aspects of medicine.
[10] H. Patisaul,et al. The pros and cons of phytoestrogens , 2010, Frontiers in Neuroendocrinology.
[11] D. Murphy,et al. Estrogen therapy and Alzheimer's dementia , 2010, Annals of the New York Academy of Sciences.
[12] T. Inakuma,et al. Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice , 2009, Journal of Bone and Mineral Metabolism.
[13] M. Marino,et al. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. , 2009, Molecular nutrition & food research.
[14] A. Bast,et al. Health effects of quercetin: from antioxidant to nutraceutical. , 2008, European journal of pharmacology.
[15] J. Heindel,et al. Effects of endocrine disruptors on obesity. , 2008, International journal of andrology.
[16] G. S. Pope,et al. Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells , 2008, The Journal of endocrinology.
[17] J. Terao,et al. Effects of quercetin and quercetin 3‐glucuronide on the expression of bone sialoprotein gene , 2007, Journal of cellular biochemistry.
[18] P. Ascenzi,et al. Structure–function relationship of estrogen receptor α and β: Impact on human health , 2006 .
[19] C. Edwards,et al. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions , 2006, British Journal of Nutrition.
[20] G. Rimbach,et al. Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. , 2005, The Journal of nutrition.
[21] A. Murk,et al. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. , 2005, Molecular nutrition & food research.
[22] J. Mazière,et al. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. , 2004, Biochemical pharmacology.
[23] Andrea Bonanome,et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. , 2002, The American journal of medicine.
[24] M. Denison,et al. Relationship between Estrogen Receptor-Binding and Estrogenic Activities of Environmental Estrogens and Suppression by Flavonoids , 2002, Bioscience, biotechnology, and biochemistry.
[25] Rui M. Rocha,et al. Interactions of Flavonoids with Iron and Copper Ions: A Mechanism for their Antioxidant Activity , 2002, Free radical research.
[26] S. Andò,et al. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. , 2001, Molecular pharmacology.
[27] A. Maggi,et al. Engineering of a mouse for the in vivo profiling of estrogen receptor activity. , 2001, Molecular endocrinology.
[28] J. Terao,et al. Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. , 2001, Free radical biology & medicine.
[29] D. Birt,et al. Dietary agents in cancer prevention: flavonoids and isoflavonoids. , 2001, Pharmacology & therapeutics.
[30] D. Barron,et al. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin , 2001, Free radical research.
[31] L Fioravanti,et al. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function , 1999, British Journal of Cancer.
[32] P. Murphy,et al. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. , 1999, The Journal of nutrition.
[33] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[34] G. Lescoat,et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. , 1993, Biochemical pharmacology.
[35] R. Coombes,et al. Characterization of estrogen receptor messenger RNA in human breast cancer. , 1987, Cancer research.
[36] T Nishihara,et al. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. , 1999, Toxicology and applied pharmacology.
[37] D. Zava,et al. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. , 1997, Nutrition and cancer.